Metamizole in the Management of Musculoskeletal Disorders: Current Concept Review

J Clin Med. 2024 Aug 14;13(16):4794. doi: 10.3390/jcm13164794.

Abstract

Metamizole, or dipyrone, has been used for decades as a non-narcotic analgesic, providing pain relief from musculoskeletal disorders and antipyretic and antispasmolytic properties. Despite being in use since the 1920s, its mechanism of action still needs to be discovered. Despite causing fewer adverse effects when compared to other analgesics, its harmful effects on the blood and lack of evidence regarding its teratogenicity make the usage of the drug questionable, which has led to it being removed from the drug market of various countries. This narrative review aims to provide a detailed insight into the mechanism of action and efficacy, comparing its effectiveness and safety with other classes of drugs and the safety profile of metamizole.

Keywords: analgesia; efficacy; metamizole; musculoskeletal disorders; pharmacokinetics; pyrazolone derivatives; safety.

Publication types

  • Review

Grants and funding

This research received no external funding.